No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial

Ajantha Solomon; Surekha Tennakoon; Edwin Leeansyah; Jose Arribas; Andrew Hill; Yvon Van Delft; Christiane Moecklinghoff; Sharon R Lewin

Journal article

No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial

Ajantha Solomon, Surekha Tennakoon, Edwin Leeansyah, Jose Arribas, Andrew Hill, Yvon Van Delft, Christiane Moecklinghoff, Sharon R Lewin

PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2014

DOI: 10.1371/journal.pone.0109718

Download PDF

University of Melbourne Researchers

Sharon Lewin Author Doherty Institute

Related Projects (1)

Improved Health Outcomes For People Living With Hiv

Despite the success of antiviral therapy for HIV infection, HIV cannot be cured and treatment is life long. In addition, there are complicat..

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia

Awarded by National Institutes for Health (NIH)

Funding Acknowledgements

The authors AH, YVD, and CM received salary from Janssen to fund part of this study. SRL is supported by the National Health and Medical Research Council (NHMRC) of Australia Practitioner Fellowship [APP1042654] and the National Institutes for Health (NIH) [grant number 1R56AI095073-01A1 and U19 AI096109]. The funders contributed to the study design, data collection and analysis, decision to publish, and preparation of the manuscript.